CXCL9 and macrophage activation syndrome: Concentrations of neopterin, IFN-γ, CXCL9, CXCL10, sCD25, and IL-18 can be used as biomarkers to determine the onset of MAS in active sJIA—even in children who have been prescribed TCZ [67,130,137,138].